- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.11.24 | FlyPharma Vienna 2024: an event to remember | ||
| 01.11.24 | The secrets of the pharmaceutical launch A-team | ||
| 31.10.24 | AbbVie to expand neuroscience pipeline with $1.4bn Aliada Therapeutics acquisition | ||
| 31.10.24 | UK life sciences sector responds to Labour government's Autumn Budget | ||
| 31.10.24 | Johnson & Johnson's Tremfya shows promise in 'special site' plaque psoriasis | ||
| 31.10.24 | Delivering inclusive events | ||
| 30.10.24 | Pfizer's Elrexfio recommended by NICE to treat relapsed and refractory multiple myeloma | ||
| 30.10.24 | Eli Lilly shares positive results for modified titration of Alzheimer's drug donanemab | ||
| 30.10.24 | Serving up customer experience excellence | ||
| 29.10.24 | Merck acquires oncology spinout Modifi Biosciences in deal worth $1.3bn | ||
| 29.10.24 | BeiGene's Tevimbra recommended by CHMP for gastric and oesophageal cancer | ||
| 29.10.24 | Medicines can be beyond reach - unless… | ||
| 28.10.24 | J&J's Darzalex regimen approved by EC for newly diagnosed multiple myeloma | ||
| 28.10.24 | Novartis' Kisqali receives CHMP recommendation for early breast cancer patients | ||
| 28.10.24 | The role of innovation in shaping the future of health communications | ||
| 25.10.24 | Pfizer and Triana enter molecular glue degrader partnership worth over $1.5bn | ||
| 25.10.24 | AstraZeneca's Voydeya recommended by NICE to treat rare blood disorder PNH | ||
| 25.10.24 | ESMO 2024 - how pharma is breathing life into cancer comms | ||
| 24.10.24 | Eli Lilly's Alzheimer's drug Kisunla approved by MHRA but not recommended by NICE | ||
| 24.10.24 | Ipsen's Iqirvo recommended by NICE to treat rare liver disease primary biliary cholangitis | ||
| 24.10.24 | Unlocking potential: key life sciences priorities for the Autumn Budget | ||
| 24.10.24 | Investment and impact: navigating the complexities of a European launch | ||
| 23.10.24 | Merck's Keytruda recommended by NICE to reduce risk of lung cancer recurrence | ||
| 23.10.24 | AstraZeneca/Ionis' Wainzua receives positive CHMP opinion to treat rare disease ATTRv-PN | ||
| 23.10.24 | Inizio Medical appoints Patrick Giordani as senior vice president, AI solutions architect |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
